According to a new report from Intel Market Research, the global Peripheral Orbital Atherectomy Devices market was valued at USD 297 million in 2024 and is projected to reach USD 446 million by 2032, growing at a CAGR of 5.6% during the forecast period (2025β2032). This growth is propelled by the increasing global prevalence of peripheral artery disease, technological advancements in minimally invasive vascular interventions, and growing adoption of orbital atherectomy for calcified lesion treatment.
Peripheral orbital atherectomy devices are specialized medical instruments designed to remove calcified plaque from peripheral arteries, restoring blood flow in patients with peripheral artery disease (PAD). These innovative devices utilize an eccentrically mounted, diamond-coated crown that orbits within the vessel, effectively sanding down hardened deposits while preserving healthy arterial tissue. This minimally invasive approach enhances vessel compliance and improves outcomes for subsequent interventions like angioplasty and stenting.
Marketed under brand names such as Diamondback 360 and Stealth 360, these devices are administered via catheter-based systems and are currently approved for commercial use in major markets including the U.S., European Union, and Japan, making them essential tools for treating complex calcified peripheral lesions.
π₯ Download Sample Report: https://www.intelmarketresearch.com/download-free-sample/3890/peripheral-orbtal-atherectomy-devices-market
1. Rising Prevalence of Peripheral Artery Disease
The increasing global burden of peripheral artery disease represents a significant growth driver for orbital atherectomy devices. PAD affects over 200 million people worldwide, with prevalence rising sharply in aging populations. The disease's progression often leads to severe calcification in peripheral arteries, creating substantial demand for advanced plaque modification technologies. Orbital atherectomy devices have emerged as a preferred treatment option for heavily calcified lesions, offering superior outcomes compared to traditional angioplasty.
2. Technological Advancements in Atherectomy Systems
Continuous innovation in orbital atherectomy technology is transforming peripheral vascular interventions. Recent device iterations feature enhanced crown designs with diamond particles optimized for different calcification patterns, improved torque transmission, and more precise speed control mechanisms. These advancements have expanded the range of treatable lesions while reducing procedural complications. The integration with intravascular imaging and robotic-assisted platforms is creating new possibilities for precision atherectomy.
3. Growing Preference for Minimally Invasive Procedures
The shift toward minimally invasive peripheral vascular interventions continues to gain momentum, driven by patient demand for shorter recovery times and reduced complications. Orbital atherectomy devices perfectly align with this trend, offering treatment through small access points with lower risk of infection and faster return to normal activities compared to open surgical options. Hospitals are increasingly investing in hybrid operating rooms equipped for these procedures, further supporting market expansion.
High procedure costs: Complete atherectomy systems can cost between $14,000-$18,000 per procedure, creating adoption challenges in price-sensitive regions
Limited reimbursement in emerging markets: Many developing healthcare systems lack dedicated reimbursement codes for these advanced interventions
Technical complexity: Orbital atherectomy requires specialized training and a steep learning curve, limiting adoption to high-volume centers with experienced staff
The global expansion of vascular care capabilities, combined with increasing physician expertise in complex interventions, presents a favorable outlook. Regions such as Asia-Pacific, Latin America, and Middle East & Africa are witnessing growing momentum through:
Improved healthcare infrastructure
Expanded interventional cardiology training programs
Strategic partnerships between global manufacturers and local distributors
Notably, leading medical device companies have announced their expansion strategies focusing on:
Development of next-generation devices with enhanced safety profiles
Clinical trials for expanded indications in below-the-knee interventions
Training initiatives to build physician proficiency in emerging markets
π₯ Download Sample PDF: https://www.intelmarketresearch.com/download-free-sample/3890/peripheral-orbtal-atherectomy-devices-market
North America: Leads global market share owing to advanced healthcare infrastructure, high procedure volumes, and favorable reimbursement policies
Europe: Strong adoption driven by well-established vascular intervention programs and increasing prevalence of calcified peripheral lesions
Asia-Pacific: Emerging as the fastest-growing region due to improving healthcare access, rising PAD incidence, and expanding medical infrastructure
Latin America: Showing promising growth in major healthcare markets with increasing investment in advanced medical technologies
Middle East & Africa: Demonstrating growth potential through medical tourism hubs and government healthcare modernization initiatives
By Product Type
Pneumatic Systems
Electric Systems
Battery-operated Devices
Corded Devices
By Application
Lower Extremity Arteries
Renal Arteries
Iliac Arteries
Other Peripheral Vessels
By End User
Hospitals
Ambulatory Surgical Centers
Specialty Cardiology Centers
Academic Research Institutions
By Technology
Diamond-coated Crown Technology
Rotational Burr Systems
Orbital Atherectomy Platforms
Hybrid Technology Systems
By Region
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
π Get Full Report: https://www.intelmarketresearch.com/medical-devices/3890/peripheral-orbtal-atherectomy-devices-market
The global peripheral orbital atherectomy devices market features a competitive landscape dominated by established medical device companies with strong cardiovascular portfolios. Boston Scientific and Medtronic currently lead the market, leveraging their extensive distribution networks and clinical support capabilities. These industry giants are continuously enhancing their device platforms through research and development, focusing on improving procedural efficiency and patient outcomes.
Emerging players and specialized cardiovascular companies are also making significant strides, particularly through innovative technologies that address specific clinical challenges in peripheral vascular interventions. The competitive environment is characterized by ongoing technological innovation, strategic acquisitions, and expansion into underserved geographical markets.
The report provides comprehensive competitive profiling of key players, including:
Abbott Cardiovascular
Boston Scientific Corporation
Medtronic plc
Philips Healthcare
Avinger, Inc.
Becton, Dickinson and Company
Merit Medical Systems
Terumo Corporation
Cook Medical
Jiaxing Jiangxin Medical Technology
Global and regional market forecasts from 2025 to 2032
Strategic insights into technological developments and regulatory approvals
Market share analysis and competitive landscape assessment
Pricing analysis and reimbursement scenario overview
Comprehensive segmentation by product type, application, end user, and geography
π Get Full Report: https://www.intelmarketresearch.com/medical-devices/3890/peripheral-orbtal-atherectomy-devices-market
π₯ Download Sample PDF: https://www.intelmarketresearch.com/download-free-sample/3890/peripheral-orbtal-atherectomy-devices-market
Intel Market Research is a leading provider of strategic intelligence, offering actionable insights in medical devices, healthcare technology, and clinical innovations. Our research capabilities include:
Real-time competitive benchmarking
Global clinical trial pipeline monitoring
Country-specific regulatory and pricing analysis
Over 500+ healthcare reports annually
Trusted by Fortune 500 companies, our insights empower decision-makers to drive innovation with confidence.
π Website: https://www.intelmarketresearch.com
π International: +1 (332) 2424 294
π Asia-Pacific: +91 9169164321
π LinkedIn: Follow Us